缬沙坦、卡托普利或合用治疗心力衰竭和(或)左室功能不全——VALIANT
出处
《中国医刊》
CAS
2004年第4期62-62,共1页
Chinese Journal of Medicine
参考文献6
-
1Pitt B,Remme W,Zannard F,et al.Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction[].The New England Journal of Medicine.2003
-
2Dahlof B,Devereux RB,Kjeldsen SE,et al.Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension Study[].The Lancet.2002
-
3Dickstein K,Kjekshus J.Effects of losartan and captopril on mortality and morbidity in high-risk patients after myocardial infarction: the OPTIMAAL randomized trial[].The Lancet.2002
-
4Mann DL and Deswal A.Angiotensin-receptor in acute myocardial infarction-A matter of dose[].The New England Journal of Medicine.2003
-
5Pitt B,Poole-Wilson PA,Segal R,et al.Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial-the Lasartan Heart Failure Survival Study ELITE II[].The Lancet.2000
-
6Brenner BM,Cooper ME,de Zeeuw D,et al.Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and Nephropathy[].The New England Journal of Medicine.2001
-
1缬沙坦急性心肌梗死试验(VALIANT)[J].岭南心血管病杂志,2000,6(4).
-
2侯维宁,陈锐,钟世勤,李慧敏,钱隽,林海真.无创正压通气治疗急性心肌梗死并重度心衰临床研究[J].国外医学（呼吸系统分册）,2005,25(12):953-953. 被引量：2
-
3缬沙坦急性心肌梗死(VALIANT)试验[J].国外医学（心血管疾病分册）,2004,31(3).
-
4Aguilar D.,Solomon S.D.,Koφber L.,郝广华.新近诊断及先前已知的糖尿病和急性心肌梗死后1年结局:缬沙坦在急性心肌梗死中的应用试验(VALIANT)[J].世界核心医学期刊文摘（心脏病学分册）,2005,0(3):26-27. 被引量：1
-
5MarcPfeffer.缬沙坦急性心肌梗死（VALIANT）试验[J].中华心血管病杂志,2004,32(5).
-
6对高危心肌梗死患者的危险评价及分层:从VALIANT临床试验获得的启示[J].世界核心医学期刊文摘（心脏病学分册）,2005,0(9):4-6.
-
7赵德生,佘强.血管紧张素转化酶抑制剂和血管紧张素Ⅱ受体拮抗剂联合应用治疗高血压病的研究进展[J].中华高血压杂志,2006,14(12):957-959. 被引量：3
-
8Sampson U.K.,Pfeffer M.A.,McMurray J.J.V.,S.D. Solomon,王海玲.急性心肌梗死后高危患者卒中的预测因素:VALIANT试验探析[J].世界核心医学期刊文摘（心脏病学分册）,2007,0(8):37-38.
-
9吴弘.JIKEI HEART研究解读[J].中国实用内科杂志,2006,26(11).
-
10马虹.(8)血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体拮抗剂在心力衰竭治疗中的作用[J].中国循环杂志,2006,21(3):165-167. 被引量：10
